Company Profile

Fluorescence Innovations Inc
Profile last edited on: 5/21/18      CAGE: 4DZL9      UEI: ML7PY8M4DGL1

Business Identifier: Fluorescence lifetime spectrophotometer
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1311 4th Street SE PO Box 13205
Minneapolis, MN 55414
Location: Single
Congr. District: 05
County: Hennepin

Public Profile

Fluorescence Innovations is organized around instrumentation to measures the fluorescence lifetime properties of biological systems. Offering a combination of speed, precision and data quality, the firm's proprietary Direct Waveform Recording(TM) technology can be used to solve a wide range analytical problems. The firm's NovaFluor PR Plate Reader instrument to utilize Direct Waveform Recording.. Protein Conformation One application of the firm's NovaFluor PR is the high throughput determination of protein conformation. High quality results can be obtained on microgram quantities of protein at read speeds of up to five samples per second. Another area where the NovaFluor PR provides superior performance is binding assays where a ligand attaches to a protein This includes enzyme inhibtor and competitive displacement assays. If you see a change in fluorescence intensity we can probably improve the quality of your data. A third application of the firm's Direct Waveform Recording™ technology is the high throughput measurement of fluorescent proteins expressed in live cells. This "cells in wells" approach yields data similar to HCS - bu tmore quickly

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $275,284
Project Title: Long-Wavelength Fret Pairs for Fluorescence Lifetime Hts Assays in Living Cells
2016 2 NIH $1,753,929
Project Title: Live-Cell Fluorescence Lifetime Fret Assays for Hts
2007 1 NIH $202,972
Project Title: New Experimental and Computational Tools for Tissue Engineering
2006 2 NIH $375,474
Project Title: Fluorescence Lifetime-Based Kinase Assay for HTS

Key People / Management

  Gregory D Gillispie -- President

  Benjamin Grant -- Engineer

  Kirk D Hartel

  Kurt Peterson -- Vice President of Engineering

  Kat Pomasi -- Operations Manager / Scientist